600422 昆药集团
交易中 07-16 10:31:20
资讯
新帖
简况
股市必读：昆药集团（600422）预计2026年1-6月归属净利润亏损3.3亿元至4亿元
证券之星 · 07-15 01:50
股市必读：昆药集团（600422）预计2026年1-6月归属净利润亏损3.3亿元至4亿元
昆药集团（600422）披露2026年半年度业绩预告，7月14日股价上涨1.48%
证券之星 · 07-14 22:26
昆药集团（600422）披露2026年半年度业绩预告，7月14日股价上涨1.48%
每周股票复盘：昆药集团（600422）3款血塞通产品新入基药目录
证券之星 · 07-12
每周股票复盘：昆药集团（600422）3款血塞通产品新入基药目录
昆药集团（600422）披露公司产品新纳入《国家基本药物目录（2026年版）》公告，7月10日股价上涨1.84%
证券之星 · 07-10
昆药集团（600422）披露公司产品新纳入《国家基本药物目录（2026年版）》公告，7月10日股价上涨1.84%
每周股票复盘：昆药集团（600422）高管变动及薪酬制度更新
证券之星 · 07-05
每周股票复盘：昆药集团（600422）高管变动及薪酬制度更新
昆药集团（600422）披露高级管理人员变更公告，6月29日股价上涨4.55%
证券之星 · 06-29
昆药集团（600422）披露高级管理人员变更公告，6月29日股价上涨4.55%
每周股票复盘：昆药集团（600422）拟注册发行不超10亿元债务融资工具
证券之星 · 06-28
每周股票复盘：昆药集团（600422）拟注册发行不超10亿元债务融资工具
昆药集团（600422）披露2025年年度股东会会议资料，6月22日股价下跌0.74%
证券之星 · 06-22
昆药集团（600422）披露2025年年度股东会会议资料，6月22日股价下跌0.74%
昆药集团：公司多渠道布局品牌传播
证券日报 · 06-16
昆药集团：公司多渠道布局品牌传播
股市必读：昆药集团（600422）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：昆药集团（600422）6月1日董秘有最新回复
昆药集团涨6.05%，东吴证券二个月前给出“买入”评级
证券之星 · 06-01
昆药集团涨6.05%，东吴证券二个月前给出“买入”评级
昆药集团：当前公司正抓紧排产以满足市场需求
证券之星 · 06-01
昆药集团：当前公司正抓紧排产以满足市场需求
5月14日昆药集团发布公告，股东增持730.38万股
证券之星 · 05-14
5月14日昆药集团发布公告，股东增持730.38万股
每周股票复盘：昆药集团（600422）因股价跌幅偏离上榜龙虎榜
证券之星 · 05-02
每周股票复盘：昆药集团（600422）因股价跌幅偏离上榜龙虎榜
港股异动 | 华润医药(03320)早盘跌超5% 旗下多家公司发布一季度业绩 昆药集团首次一季度亏损
智通财经网 · 04-27
港股异动 | 华润医药(03320)早盘跌超5% 旗下多家公司发布一季度业绩 昆药集团首次一季度亏损
异动快报：昆药集团（600422）4月27日9点34分触及跌停板
证券之星 · 04-27
异动快报：昆药集团（600422）4月27日9点34分触及跌停板
营收退回十年前、单季亏1.42亿，昆药集团转型阵痛待破局
21世纪经济报道 · 04-27
营收退回十年前、单季亏1.42亿，昆药集团转型阵痛待破局
昆药集团(600422)3月31日股东户数5.56万户，较上期增加0.29%
证券之星 · 04-25
昆药集团(600422)3月31日股东户数5.56万户，较上期增加0.29%
图解昆药集团一季报：第一季度单季净利润同比下降256.70%
证券之星 · 04-25
图解昆药集团一季报：第一季度单季净利润同比下降256.70%
华润医药(03320)：昆药集团一季度净亏损1.45亿元 同比盈转亏
智通财经 · 04-24
华润医药(03320)：昆药集团一季度净亏损1.45亿元 同比盈转亏
加载更多
公司概况
公司名称：
昆药集团股份有限公司
所属行业：
医药制造业
上市日期：
2000-12-06
主营业务：
昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是心脑血管治疗领域、骨科系列、抗疟类、妇科、消化系统、其他、药品、器械批发与零售。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业，全国医药制造业百强企业。
发行价格：
10.22
{"stockData":{"symbol":"600422","market":"SH","secType":"STK","nameCN":"昆药集团","latestPrice":9.12,"timestamp":1784169080000,"preClose":8.84,"halted":0,"volume":13098067,"delay":0,"changeRate":0.0317,"floatShares":757000000,"shares":757000000,"eps":0.1555,"marketStatus":"交易中","change":0.28,"latestTime":"07-16 10:31:20","open":8.73,"high":9.15,"low":8.7,"amount":117000000,"amplitude":0.0509,"askPrice":9.13,"askSize":166,"bidPrice":9.12,"bidSize":34,"shortable":0,"etf":0,"ttmEps":0.1555,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1784172600000},"marketStatusCode":2,"adr":0,"adjPreClose":8.84,"symbolType":"stock","openAndCloseTimeList":[[1784165400000,1784172600000],[1784178000000,1784185200000]],"highLimit":9.72,"lowLimit":7.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":756975757,"isCdr":false,"pbRate":1.28,"roa":"--","peRate":58.649518,"roe":"--","epsLYR":0.46,"committee":-0.708931,"marketValue":6904000000,"turnoverRate":0.0173,"status":0,"floatMarketCap":6904000000},"requestUrl":"/m/hq/s/600422/","defaultTab":"news","newsList":[{"id":"2651548365","title":"股市必读：昆药集团（600422）预计2026年1-6月归属净利润亏损3.3亿元至4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651548365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651548365?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:50","pubTimestamp":1784051419,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，昆药集团报收于8.91元，上涨1.48%，换手率2.98%，成交量22.54万手，成交额2.01亿元。业绩披露要点：昆药集团预计2026年1-6月归属净利润亏损3.3亿元至4亿元，扣非后净利润亏损3.5亿元至4.3亿元。公司公告汇总昆药集团2026年半年度业绩预告昆药集团股份有限公司预计2026年半年度实现归属于上市公司股东的净利润为-40,000万元到-33,000万元，扣除非经常性损益后的净利润为-43,000万元到-35,000万元，较上年同期出现大幅下滑并由盈转亏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810412","title":"昆药集团（600422）披露2026年半年度业绩预告，7月14日股价上涨1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810412","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651810412?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:26","pubTimestamp":1784039176,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，昆药集团报收于8.91元，较前一交易日上涨1.48%，最新总市值为67.45亿元。该股当日开盘8.73元，最高9.08元，最低8.52元，成交额达2.01亿元，换手率为2.98%。近日，昆药集团股份有限公司披露2026年半年度业绩预告。公告显示，公司预计2026年半年度实现归属于上市公司股东的净利润为-40,000万元到-33,000万元，扣除非经常性损益后的净利润为-43,000万元到-35,000万元，较上年同期出现大幅下滑并由盈转亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0188","600422","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650892152","title":"每周股票复盘：昆药集团（600422）3款血塞通产品新入基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650892152","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650892152?lang=zh_cn&edition=full","pubTime":"2026-07-12 03:22","pubTimestamp":1783797730,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，昆药集团报收于8.28元，较上周的8.27元上涨0.12%。本周，昆药集团7月6日盘中最高价报8.63元。7月10日盘中最低价报7.96元。昆药集团当前最新总市值62.68亿元，在中药板块市值排名32/66，在两市A股市值排名2655/5202。公司共57个产品进入该目录，新增3个产品。血塞通系列为核心中成药，2025年相关产品销售收入约90,242.25万元，占公司营业收入的13.72%。此次纳入将提升产品在基层医疗市场的可及性，支持慢病管理和银发健康战略。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200001287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0028","600422","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650136978","title":"昆药集团（600422）披露公司产品新纳入《国家基本药物目录（2026年版）》公告，7月10日股价上涨1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650136978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650136978?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:48","pubTimestamp":1783694896,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，昆药集团报收于8.28元，较前一交易日上涨1.84%，最新总市值为62.68亿元。近日，昆药集团发布关于公司产品新纳入《国家基本药物目录》的公告。根据国家卫生健康委员会等部门发布的通知，昆药集团股份有限公司的络泰血塞通软胶囊、控股子公司昆明华润圣火药业有限公司的理洫王血塞通软胶囊、昆药集团血塞通药业股份有限公司的络泰血塞通滴丸新纳入《国家基本药物目录》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000045023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422","BK0060","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649694203","title":"每周股票复盘：昆药集团（600422）高管变动及薪酬制度更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694203","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649694203?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:57","pubTimestamp":1783191428,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，昆药集团报收于8.27元，较上周的7.7元上涨7.4%。本周，昆药集团7月2日盘中最高价报8.53元。来自公司公告汇总：昆药集团通过2026年董事及高管薪酬方案，绩效年薪占比不低于60%。公司公告汇总昆药集团董事会于2026年6月29日收到刘军锋先生的书面辞职报告，其因个人原因申请辞去公司高级副总裁职务，辞任后不再担任公司任何职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","600422","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647308861","title":"昆药集团（600422）披露高级管理人员变更公告，6月29日股价上涨4.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647308861","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647308861?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:40","pubTimestamp":1782744026,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，昆药集团报收于8.05元，较前一交易日上涨4.55%，最新总市值为60.94亿元。该股当日开盘7.66元，最高8.14元，最低7.45元，成交额达8338.21万元，换手率为1.4%。近日，昆药集团发布《关于高级管理人员变更的公告》。公告显示，公司董事会于2026年6月29日收到刘军锋先生的书面辞职报告，因其个人原因申请辞去公司高级副总裁职务，辞任后不再担任公司任何职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600422","BK0028","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646431531","title":"每周股票复盘：昆药集团（600422）拟注册发行不超10亿元债务融资工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2646431531","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646431531?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:13","pubTimestamp":1782587589,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，昆药集团报收于7.7元，较上周的8.09元下跌4.82%。本周，昆药集团6月23日盘中最高价报8.34元。6月26日盘中最低价报7.7元，股价触及近一年最低点。昆药集团当前最新总市值58.29亿元，在中药板块市值排名32/66，在两市A股市值排名2814/5206。会议听取了三位独立董事的述职报告。董事会总结了2025年在战略发展、公司治理、风险防控等方面的工作，并提出了2026年工作计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","600422","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645732620","title":"昆药集团（600422）披露2025年年度股东会会议资料，6月22日股价下跌0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645732620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645732620?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:37","pubTimestamp":1782139036,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，昆药集团报收于8.03元，较前一交易日下跌0.74%，最新总市值为60.79亿元。该股当日开盘8.07元，最高8.07元，最低7.76元，成交额达6630.81万元，换手率为1.11%。近日，昆药集团披露《2025年年度股东会会议资料》。公告显示，公司召开2025年年度股东会，审议并通过了2025年度董事会工作报告、利润分配方案、相关人员年度报酬、薪酬管理制度、2026年度董事及高管薪酬方案、拟注册发行不超过10亿元债务融资工具等议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0028","BK0239","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643750783","title":"昆药集团：公司多渠道布局品牌传播","url":"https://stock-news.laohu8.com/highlight/detail?id=2643750783","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643750783?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:42","pubTimestamp":1781613720,"startTime":"0","endTime":"0","summary":"证券日报网讯 6月16日，昆药集团在互动平台回答投资者提问时表示，关于品牌宣传投放，公司多渠道布局品牌传播，央媒、地方权威媒体、健康科普平台、线下终端等均有分层投放布局；今年一季度，公司依托昆中药“脾胃大师”IP，携手《味道大师》美食纪录片登陆央视财经频道开展品牌露出。此外，在宣传形式方面，包含品牌形象推广、科普栏目、健康公开课等多元形式，相关投放根据年度品牌规划、销售周期动态调配。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-16/doc-inicrivp4306737.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-16/doc-inicrivp4306737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0060","BK0239","BK0028","BK0188","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640969514","title":"股市必读：昆药集团（600422）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640969514","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640969514?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:22","pubTimestamp":1780338134,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，昆药集团报收于9.47元，上涨6.05%，换手率3.14%，成交量23.75万手，成交额2.2亿元。董秘最新回复投资者： 公司官方店的昆药生物肽牙膏卖缺货了，公司负责这个的领导是个吃白饭的请抓紧补货？后续公司将持续强化供应链统筹，保障产品的稳定供应。交易信息汇总资金流向6月1日主力资金净流入287.76万元，占总成交额1.31%；游资资金净流出3030.62万元，占总成交额13.79%；散户资金净流入2742.86万元，占总成交额12.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422","BK0239","BK0188","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640328149","title":"昆药集团涨6.05%，东吴证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2640328149","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640328149?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:34","pubTimestamp":1780302855,"startTime":"0","endTime":"0","summary":"今日昆药集团（600422）涨6.05%，收盘报9.47元。2026年3月24日，东吴证券研究员朱国广,向潇发布了对昆药集团的研报《2025年报点评：短期业绩承压，银发经济长期发展向好》，该研报对昆药集团给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为44.45%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为华泰证券的高初蕾。昆药集团（600422）个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100024406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640939792","title":"昆药集团：当前公司正抓紧排产以满足市场需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2640939792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640939792?lang=zh_cn&edition=full","pubTime":"2026-06-01 15:33","pubTimestamp":1780299203,"startTime":"0","endTime":"0","summary":"证券之星消息，昆药集团(600422)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问：公司官方店的昆药生物肽牙膏卖缺货了，公司负责这个的领导是个吃白饭的请抓紧补货？昆药集团回复：尊敬的投资者，您好。当前公司正抓紧排产以满足市场需求，敬请关注官方渠道到货动态。后续公司将持续强化供应链统筹，保障产品的稳定供应。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100017148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0028","BK0188","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635712116","title":"5月14日昆药集团发布公告，股东增持730.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635712116","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635712116?lang=zh_cn&edition=full","pubTime":"2026-05-14 20:01","pubTimestamp":1778760067,"startTime":"0","endTime":"0","summary":"证券之星消息，5月14日昆药集团发布公告《昆药集团:昆药集团关于控股股东权益变动触及1%刻度的提示性公告》，其股东华润三九医药股份有限公司于2026年4月27日至2026年5月14日间合计增持730.38万股，占公司目前总股本的0.9649%，变动期间该股股价下跌18.52%，截止5月14日收盘报8.93元。股东增减持详情见下表：根据昆药集团2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400038414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","600422","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623768","title":"每周股票复盘：昆药集团（600422）因股价跌幅偏离上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632623768?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:33","pubTimestamp":1777674789,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，昆药集团报收于9.5元，较上周的10.96元下跌13.32%。本周，昆药集团4月27日盘中最高价报9.95元。本周关注点交易信息汇总：昆药集团因日收盘价格跌幅偏离值达7%登上龙虎榜交易信息汇总：此次为近5个交易日内第1次上榜交易信息汇总沪深交易所2026年4月27日公布的交易公开信息显示，昆药集团因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","600422","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630356686","title":"港股异动 | 华润医药(03320)早盘跌超5% 旗下多家公司发布一季度业绩 昆药集团首次一季度亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2630356686","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630356686?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:18","pubTimestamp":1777259883,"startTime":"0","endTime":"0","summary":"华润医药(03320)早盘跌超5%，截至发稿，跌5.54%，报54.6港元，成交额8960.6万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260427/20260427111827_60015.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260427/20260427111827_60015.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03320","BK4588","BK0060","BK0239","BK4585","BK1191","VXUS","BK1570","BK0028","BK0188","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630643358","title":"异动快报：昆药集团（600422）4月27日9点34分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2630643358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630643358?lang=zh_cn&edition=full","pubTime":"2026-04-27 09:36","pubTimestamp":1777253788,"startTime":"0","endTime":"0","summary":"证券之星4月27日盘中消息，9点34分昆药集团（600422）触及跌停板。其所属行业中药目前上涨。领涨股为济川药业。该股为大农业，农业种植，口腔概念热股。4月24日的资金流向数据方面，主力资金净流出1000.61万元，占总成交额13.47%，游资资金净流出311.34万元，占总成交额4.19%，散户资金净流入1311.94万元，占总成交额17.66%。近5日资金流向一览见下表：昆药集团主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700010094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","600422","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630358404","title":"营收退回十年前、单季亏1.42亿，昆药集团转型阵痛待破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2630358404","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630358404?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:30","pubTimestamp":1777249800,"startTime":"0","endTime":"0","summary":" 4月24日晚，昆药集团发布2026年第一季度财报，交出了一份近十年来最为低迷的季度成绩单。 财报显示，今年一季度公司实现营收8.36亿元，同比大幅下滑48.01%，回落至十年前水平；归母净利润亏损1.42亿元，出现20年来一季度首次亏损；经营活动现金流净额跌至-6.14亿元，创下20年来一季度新低。 梳理财报可见，昆药集团收入和利润端的下滑并非突发。 2023年至2025年，公司营收分别同比下降6.99%、0.34%、21.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-27/doc-inhvwwms7939250.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-27/doc-inhvwwms7939250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870898","title":"昆药集团(600422)3月31日股东户数5.56万户，较上期增加0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870898?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:03","pubTimestamp":1777107804,"startTime":"0","endTime":"0","summary":"证券之星消息，近日昆药集团披露，截至2026年3月31日公司股东户数为5.56万户，较2月28日增加158.0户，增幅为0.29%。在中药行业个股中，昆药集团股东户数高于行业平均水平，截至3月31日，中药行业平均股东户数为5.31万户。从股价来看，2026年2月28日至2026年3月31日，昆药集团区间跌幅为7.17%，在此期间股东户数增加158.0户，增幅为0.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500031904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","BK0188","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630582121","title":"图解昆药集团一季报：第一季度单季净利润同比下降256.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630582121","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630582121?lang=zh_cn&edition=full","pubTime":"2026-04-25 02:18","pubTimestamp":1777054735,"startTime":"0","endTime":"0","summary":"证券之星消息，昆药集团2026年一季报显示，一季度公司主营收入8.36亿元，同比下降48.01%；归母净利润-1.42亿元，同比下降256.7%；扣非净利润-1.9亿元，同比下降363.98%；负债率39.39%，投资收益1962.75万元，财务费用1062.15万元，毛利率22.57%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500006474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629845690","title":"华润医药(03320)：昆药集团一季度净亏损1.45亿元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2629845690","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629845690?lang=zh_cn&edition=full","pubTime":"2026-04-24 19:29","pubTimestamp":1777030156,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布昆药集团截止2026年3月31日止3个月财务业绩，该公司取得营业总收入8.36亿元，同比减少48.01%;净亏损1.45亿元，去年同期溢利1.14亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03320","BK0188","BK1570","BK0028","600422","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784169082202,"stockEarnings":[{"period":"1week","weight":0.0663},{"period":"1month","weight":0.0363},{"period":"3month","weight":-0.2163},{"period":"6month","weight":-0.3147},{"period":"1year","weight":-0.3614},{"period":"ytd","weight":-0.2962}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0345},{"period":"3month","weight":-0.0246},{"period":"6month","weight":-0.0357},{"period":"1year","weight":0.1286},{"period":"ytd","weight":-0.0033}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"昆药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"55570人(较上一季度增加0.29%)","perCapita":"13622股","listingDate":"2000-12-06","address":"云南省昆明市五华区国家高新技术产业开发区科医路166号","registeredCapital":"75697万元","survey":" 昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是心脑血管治疗领域、骨科系列、抗疟类、妇科、消化系统、其他、药品、器械批发与零售。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业，全国医药制造业百强企业。","listedPrice":10.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昆药集团,600422,昆药集团股票,昆药集团股票老虎,昆药集团股票老虎国际,昆药集团行情,昆药集团股票行情,昆药集团股价,昆药集团股市,昆药集团股票价格,昆药集团股票交易,昆药集团股票购买,昆药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}